Parsons Erin
- SEC CIK
- 0001895795
No open-market purchases or sales filed in the past year.
Current role at each company
- KPRX Kiora Pharmaceuticals IncDirectoras of Jun 12, 2026
- ALIM Alimera Sciences IncDirectoras of Sep 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Parsons Erin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KPRX Kiora Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Parsons ErinDirector | PPurchase | +5.26K | $4.88 | +$25.7K | New position5.26K after |